NDC 50090-6353-02 - BUPROPION HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6353
- Requested NDC
- 50090-6353-02
- Package NDCs from labels
- 50090-6353-3, 50090-6353-0, 50090-6353-1, 50090-6353-2, 50090-6353-02
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-05-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BUPROPION HYDROCHLORIDE - A-S Medication Solutions | A-S Medication Solutions | 2024-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6353-0 | BUPROPION HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 3 | |
| 50090-6353-1 | BUPROPION HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 3 | |
| 50090-6353-2 | BUPROPION HYDROCHLORIDE | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | 3 | |
| 50090-6353-3 | BUPROPION HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6353 | BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 4 package rows | 20240601_87dac2ee-732c-465b-8ffe-e5aeba421425.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6353-0 | EA - Each | 50090-6353 | b366b832-3c72-41c5-945d-93a7b2fe2847 | 1 | 2023-03-13 |
| 50090-6353-1 | EA - Each | 50090-6353 | 69402426-2aed-4796-b376-05bd51b0984c | 1 | 2023-03-13 |
| 50090-6353-2 | EA - Each | 50090-6353 | b222b324-814e-4a74-935d-3c77bec5d633 | 1 | 2023-03-13 |
| 50090-6353-3 | EA - Each | 50090-6353 | c4c18edd-f3f9-4c53-81d3-1dd45f343b0c | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stay Ageless Tinted Mineral Sunscreen | BROAD SPECTRUM SPF30 | W Aesthetics | 5b0f2c8f-d6fa-5e25-e063-6394a90a084d | 2026-09-09 | Warnings | 15FIX9V2JP |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Apotex Corp | 86530199-999b-9f92-b1bc-b8515ec829f3 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 136f29fa-a859-4efb-8365-1382716d6f8f | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 81d251aa-a8e8-493e-94ed-12f6fb8902e6 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion HCL ER(SR) | BUPROPION HCL ER(SR) | DriectRx | 50afb442-e7c6-d28c-e063-6294a90a2b7e | 2026-08-31 | Warnings, Adverse reactions | 993503 ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Granules Pharmaceuticals Inc. | d9eb0939-63c1-48c4-a444-a899d7924d06 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 0b041720-a25d-403e-a72c-601a8bdd8051 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | b47c5515-a438-40bc-b8ad-26a6cf9676b7 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 993518 ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 6087100f-3ba4-412e-b08d-768d1dcdaf00 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 993518 ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 0aa86bd6-b37b-45f7-a837-b067e41184e9 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 993503 ZG7E5POY8O |
| MZANK SUNSCREEN DAILY ULTIMATE PROTECTION SPF50 | SUNSCREEN SPF50 | Guangzhou Meixi Biotechnology Co., Ltd. | 5a0b4bd2-f6ad-35dc-e063-6294a90a8a66 | 2026-08-27 | Warnings | 15FIX9V2JP |
| MELAO Hydrating Lightweight Sunscreen | AVOBENZONE,ENSULIZOLE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,TITANIUM DIOXIDE | Guangdong Aimu Biological Technology Co., Ltd | 59eeaea1-d726-99f3-e063-6394a90aeea3 | 2026-08-26 | Warnings | 15FIX9V2JP |
| Bupropion Hydrochloride XL | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | bcbef1b4-a135-4231-bc65-7d0b335260e8 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride XL | BUPROPION HYDROCHLORIDE | Quallent Pharmaceuticals Health LLC | 56df4e22-81ca-48a4-a8e2-038448417355 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Q Skin Science | SUNSCREEN | International Cosmeceuticals, Inc | 59e4c3d0-ee4c-2350-e063-6394a90ac9d2 | 2026-08-25 | Warnings | 15FIX9V2JP |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 5f8b3313-0286-499f-9235-02cdc0eb063b | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 993536 993518 ZG7E5POY8O |
| MELAO zinc stick(GREEN) | TITANIUM DIOXIDE,ZINC OXIDE,OCTOCRYLENE | Guangzhou Haishi Biological Technology Co., Ltd. | 59c70c82-f7ff-9a04-e063-6294a90a7b3d | 2026-08-24 | Warnings | 15FIX9V2JP |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 334e5635-e4cc-cf2a-e063-6294a90ae1e1 | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| SKIN-INFUSED FOUNDATION SPF 25/ Mineral sunscreen broad Spectrum SPF 25 01 | ZINC OXIDE, TITANIUM DIOXIDE | Cosmuses Cosmetics (Ningbo) Co., Ltd. | 59d74e3f-e3fa-a7a9-e063-6294a90a76e5 | 2026-08-24 | Warnings | 15FIX9V2JP |
| Rohto All-In-One | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATE | The Mentholatum Company | 43e690e4-b381-46e3-838c-33aef5bdadde | 2026-08-20 | Warnings | 3NXW29V3WO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.